Rheumatoid Arthritis Clinical Trials in Ann Arbor, Michigan

4 studies are recruiting for rheumatoid arthritis in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

    This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized dose escalation and dose expansion basket study to determine the safety and tolerability of NKX019 (allogeneic CAR NK cells targeting CD19) in participants with autoimmune diseases.

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Nkarta Investigational Site, Ann Arbor, Michigan
    Locations
    18 in total
    Run by
    Nkarta, Inc.

    See if you can join NCT06733935 on ClinicalTrials.gov

  2. A Study of AZD0120 in Autoimmune Diseases

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with systemic sclerosis (SSc), idiopathic inflammatory myopathies (IIM), or difficult-to-treat rheumatoid arth…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Research Site, Ann Arbor, Michigan
    Locations
    22 in total
    Run by
    AstraZeneca

    See if you can join NCT07295847 on ClinicalTrials.gov

  3. Dynamic Treatment Regiments for Glucocorticoid Tapering

    The purpose of this clinical trial is to better understand how people with rheumatoid arthritis (RA) respond to gradual dose reduction, or "tapering", of steroid medications like prednisone. Some people with RA have symptoms when steroid dose is reduced, while others don't. This trial will look at …

    Stage
    Phase 2
    Ages
    18 and older
    Site
    VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor, Michigan
    Locations
    2 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT06072768 on ClinicalTrials.gov

  4. Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information to help us understand more about disease progressi…

    Stage
    Not phased
    Ages
    18 to 90
    Site
    University of Michigan, Ann Arbor, Michigan
    Locations
    4 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06397677 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.